ArticlePersonalized medicine2013
Personalized medicine: challenges and opportunities for translational bioinformatics.
Article in Personalized medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Making Sense of Missense: Assessing and Incorporating the Functional Impact of Constitutional Genetic Testing.Children (Basel, Switzerland) · 2025Article
- Patients' Experiences of a Precision Medicine Clinic.Journal of patient experience · 2024Article
- 3D Bioprinting for Next-Generation Personalized Medicine.International journal of molecular sciences · 2023Review
- Assessing the net benefit of machine learning models in the presence of resource constraints.Journal of the American Medical Informatics Association : JAMIA · 2023Article
- SMART COVID Navigator, a Clinical Decision Support Tool for COVID-19 Treatment: Design and Development Study.Journal of medical Internet research · 2022Article
- Systematic Identification of Genomic Markers for Guiding Iron Oxide Nanoparticles in Cervical Cancer Based on Translational Bioinformatics.International journal of nanomedicine · 2022Article
- Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions.HemaSphere · 2021Review
- Pharmacogenomics Implementation and Hurdles to Overcome; In the Context of a Developing Country.Iranian journal of pharmaceutical research : IJPR · 2021Article
- Milestones in Personalized Medicine: From the Ancient Time to Nowadays-the Provocation of COVID-19.Frontiers in genetics · 2020Review
- FHIR Genomics: enabling standardization for precision medicine use cases.NPJ genomic medicine · 2020Article
- The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes.Leukemia & lymphoma · 2019Article
- Big Data and the Study of Social Inequalities in Health: Expectations and Issues.Frontiers in public health · 2018Article
- Physicians' pharmacogenomics information needs and seeking behavior: a study with case vignettes.BMC medical informatics and decision making · 2017Article
- Article
- In silico Mapping of Protein Unfolding Mutations for Inherited Disease.Scientific reports · 2016Article
- Text mining for precision medicine: automating disease-mutation relationship extraction from biomedical literature.Journal of the American Medical Informatics Association : JAMIA · 2016Article
- Participant views on consent in cancer genetics research: preparing for the precision medicine era.Journal of community genetics · 2016Article
- Dynamic software design for clinical exome and genome analyses: insights from bioinformaticians, clinical geneticists, and genetic counselors.Journal of the American Medical Informatics Association : JAMIA · 2016Article
- Pragmatic and Ethical Challenges of Incorporating the Genome into the Electronic Medical Record.Current genetic medicine reports · 2014Article
- Empowering Personalized Medicine with Big Data and Semantic Web Technology: Promises, Challenges, and Use Cases.Proceedings : ... IEEE International Conference on Big Data. IEEE International Conference on Big Data · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Personalized medicine can be defined broadly as a model of healthcare that is predictive, personalized, preventive and participatory. Two US President's Council of Advisors on Science and Technology reports illustrate challenges in personalized medicine (in a 2008 report) and in use of health information technology (in a 2010 report). Translational bioinformatics is a field that can help address these challenges and is defined by the American Medical Informatics Association as "the development of storage, analytic and interpretive methods to optimize the transformation of increasing voluminous biomedical data into proactive, predictive, preventative and participatory health." This article discusses barriers to implementing genomics applications and current progress toward overcoming barriers, describes lessons learned from early experiences of institutions engaged in personalized medicine and provides example areas for translational bioinformatics research inquiry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.